Quoin Pharmaceuticals regains compliance with Nasdaq minimum bid price rule

Quoin Pharmaceuticals (QNRX) has received written notice from the Listing Qualifications Department of The Nasdaq Stock Market stating that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The notification from Nasdaq confirms that for the last 13 consecutive business days, the closing bid price of the Company’s ordinary shares was at or above $1.00 per share. Accordingly, Nasdaq considers the matter closed.